UVM Medical Center

Burlington, Vermont 05401

We've found

1 trials

at this facility

A Study Of Oral PF-02341066, A C-Met/Hepatocyte Growth Factor Tyrosine Kinase Inhibitor, In Patients With Advanced Cancer

Status: Enrolling, Phase I
Updated: 12/31/1969

from

Burlington, VT

Use our guide to learn which trials are right for you!